Active Pharmaceutical Ingredients CDMO Market to Reach USD 193.8 Billion by 2030 with Strong Growth in Oncology, Asia-Pacific Expansion

Mordor Intelligence has published a new report on the "Active Pharmaceutical Ingredients CDMO Market" offering a comprehensive analysis of trends, growth drivers, and future projection

The Active Pharmaceutical Ingredients CDMO Market Size is anticipated to grow from USD 128.26 billion in 2025 to USD 193.83 billion by 2030, registering a CAGR of 8.61% over this period. This expansion reflects growing demand across the drug development spectrum-for process development, near-term supply, and commercial manufacturing of high-value APIs. As pharmaceutical firms, especially in oncology and biologics, continue to outsource API production, CDMOs are stepping up with integrated service models that can handle complex molecules and large-scale supply.

Report Overview: https://www.mordorintelligence.com/industry-reports/active-pharmaceutical-ingredients-cdmo-market?utm_source=openpr

Key Trends in the Active Pharmaceutical Ingredients CDMO Market

Key Active Pharmaceutical Ingredients CDMO Market Trends shaping the market include:

Oncology remains the top application area
CDMOs are seeing the greatest demand in oncology-related API manufacturing. This reflects growing R&D pipelines targeting cancer therapies and the complexity of molecules being developed.

Synthetic and innovative drugs lead demand
APIs produced via synthetic routes and those serving innovative (rather than generic) medications hold major market share, driven by the need for complex, differentiated offerings

Commercial supply dominates workflow
A significant portion of CDMO revenue comes from commercial manufacturing, underlining the importance of end-to-end capabilities-from development to large-scale production

Asia-Pacific delivers fastest growth; North America leads in value
North America continues to account for a large portion of market share due to established biopharma industries and regulatory infrastructure. Meanwhile, Asia-Pacific-led by India and China-is expanding rapidly, driven by cost effectiveness and expanding capacity.

These trends illustrate the Active Pharmaceutical Ingredients CDMO Market Growth, particularly where advanced therapeutic areas and global outsourcing intersect.

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/active-pharmaceutical-ingredients-cdmo-market?utm_source=openpr

Market Segmentation of the Active Pharmaceutical Ingredients CDMO Market

Here is the Active Pharmaceutical Ingredients CDMO Market Segmentation, as defined in the Mordor Intelligence report

By Molecule Size

Small Molecule

Large / Biologic Molecule

By Synthesis Type

Synthetic Chemical

Biological (Fermentation / Cell Culture)

By API Complexity

Standard Potency APIs

Highly-Potent APIs (HPAPIs)

By Service Type

Process R&D & Route Scouting

cGMP Scale-Up & Commercial Manufacturing

Integrated End-to-End Services

By Therapeutic Area

Oncology

Cardiovascular & Metabolic

Anti-Infectives

Central Nervous System

Respiratory

Gastrointestinal & Hepatology

Dermatology & Aesthetics

Immunology & Rare Diseases

By Customer Type

Big Pharma companies

Mid-Size Pharma

Small Biotech

Others

By Phase

Pre-clinical

Phase I

Phase II

Phase III

Commercial

By Geography

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

This segmentation highlights the comprehensive scope of the Active Pharmaceutical Ingredients CDMO Industry, spanning diverse product types, therapeutic fields, and global regions.

Explore Our Full Library of Healthcare Industry Research Reports

https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=openpr

Key Players in the Active Pharmaceutical Ingredients CDMO Industry

Leading companies in the Active Pharmaceutical Ingredients CDMO Market Share include:

Catalent, Inc.

Cambrex Corporation

Lonza Group

Recipharm AB

Astorg (Corden Pharma)

These firms are recognized for offering wide-ranging capabilities-from early-stage API development to full-scale commercial production. They form the backbone of the global Active Pharmaceutical Ingredients CDMO Industry, delivering specialist services to pharmaceutical clients worldwide.

To know more about the major players in the market, visit: https://www.mordorintelligence.com/industry-reports/active-pharmaceutical-ingredients-cdmo-market/companies?utm_source=openpr

Conclusion

The market demand is driven by oncology pipelines, synthetic and innovative drugs, and commercial-scale supply needs. Asia-Pacific is expanding rapidly, while North America retains its leading position in market value.

A diverse array of CDMOs-from global players to regional specialists-is meeting the industry's rising need for integrated services. As pharmaceutical development continues to move toward complex molecules and biologics, the Active Pharmaceutical Ingredients CDMO Market Growth appears set to continue.

For complete Active Pharmaceutical Ingredients CDMO Market Analysis, visit the Mordor Intelligence page: https://www.mordorintelligence.com/industry-reports/active-pharmaceutical-ingredients-cdmo-market?utm_source=openpr

Industry Related Reports

Pharmaceutical Contract Development And Manufacturing Organization (CDMO) Market: The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report is Segmented by Service Type (API Manufacturing, and More), Molecule Type (Small Molecule, and More), Dosage Form (Solid Oral, Sterile Injectables, and More), Therapeutic Area (Oncology, Metabolic and Endocrine, and More), and Geography.
Get More Insights: https://www.mordorintelligence.com/industry-reports/pharmaceutical-contract-development-and-manufacturing-organization-cdmo-market?utm_source=openpr

China Active Pharmaceutical Ingredients (API) Market: The Chinese Active Pharmaceutical Ingredients (API) Market Report is Segmented by Business Mode (Captive API and Merchant API), Synthesis Type (Synthetic and Biotech), Drug Type (Generic and Branded), and Application (Cardiology, Oncology, Pulmonology, Neurology, Orthopedic, Ophthalmology, and Other Applications).
Get More Insights: https://www.mordorintelligence.com/industry-reports/china-active-pharmaceutical-ingredients-market?utm_source=openpr

Veterinary Active Pharmaceutical Ingredients (API) Market: The report covers Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market and it is Segmented by Product (Antiparasitic, Anti-infectives, Vaccines, NSAIDs, and Others), Synthesis Type (Chemical Based API, Biological API, and Highly potent API (HPAPI)), Service Type (In House, and Contract Outsourcing) and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America).
Get More Insights: https://www.mordorintelligence.com/industry-reports/veterinary-active-pharmaceutical-ingredients-manufacturing-market?utm_source=openpr

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

Mordor Intelligence, 11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli, Hyderabad, Telangana - 500032, India

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/

This release was published on openPR.